Neural and Psychiatric Consequences of Cannabis Use in Adolescents
NCT06941298 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2026-04-22
Summary
The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.
Conditions
- Cannabis Use
- Depression
Interventions
- BEHAVIORAL
-
Neuroimaging Investigation
Participants will undergo fMRI neuroimaging at two timepoints, at the start of the study and at the 1 year follow up. The fMRI is one hour in duration. During the fMRI, participants will complete two tasks investigating diverse aspects of reward circuitry activity. After this is completed, participants will be followed up for another year clinically.
Sponsors & Collaborators
-
Nathan Kline Institute for Psychiatric Research
collaborator OTHER -
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Miami
lead OTHER
Principal Investigators
-
Vilma Gabbay, MD, JD, MS · University of Miami
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-04
- Primary Completion
- 2029-06-01
- Completion
- 2029-06-01
Countries
- United States
Study Locations
More Related Trials
-
TRIAD Project: Qualitative Study of Adolescent Depression and Smoking
NCT00592696 ·Status: COMPLETED
-
Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents
NCT02498925 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring
NCT02865629 ·Status: UNKNOWN ·Phase: NA
-
Characterization and Treatment of Adolescent Depression
NCT03388606 ·Status: RECRUITING
-
Cognitive Training for Depression
NCT01936506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder
NCT06203015 ·Status: RECRUITING
-
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
NCT02855580 ·Status: COMPLETED
-
Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders
NCT01769859 ·Status: TERMINATED
-
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study
NCT02739932 ·Status: COMPLETED
-
Intravenous Ketamine Plus Neurocognitive Training for Depression
NCT03237286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurocognitive Enhancement in Major Depressive Disorder
NCT00998569 ·Status: COMPLETED ·Phase: NA
-
A Randomized Neuroimaging Trial of Psilocybin in Depression
NCT06072898 ·Status: RECRUITING ·Phase: PHASE2
-
MRI Studies of Emotion in Depression
NCT02429011 ·Status: COMPLETED
-
Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
NCT07247344 ·Status: RECRUITING
-
Cognitive Training for Depression II
NCT01934491 ·Status: COMPLETED ·Phase: NA
-
Quetiapine in Melancholic Depression
NCT01200901 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Imaging in Depression
NCT00050700 ·Status: COMPLETED
-
Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
NCT04701866 ·Status: COMPLETED ·Phase: NA
-
Social Media Concerns Related to Emotional Experiences in Naturalistic Settings (SCREENS)
NCT07278752 ·Status: NOT_YET_RECRUITING
-
Heart Disease Risk Factors in Major Depression
NCT00001969 ·Status: COMPLETED
-
Internet-Based Depression Screening for College Students
NCT01326793 ·Status: COMPLETED ·Phase: NA
-
Treatment Resistant Geriatric Depression in Primary Care
NCT01392287 ·Status: COMPLETED ·Phase: PHASE1
-
Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents
NCT05571878 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
NCT01529905 ·Status: UNKNOWN
-
The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
NCT02443636 ·Status: RECRUITING